Back to search

Article

C-kit+VEGFR-2+ Mesenchymal Stem Cells Differentiate into Cardiovascular Cells and Repair Infarcted Myocardium after Transplantation

2022-01-11

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Resent preclinical studies and clinical trails prove that transplantation of mesenchymal stem cells (MSCs) is a promised therapy for ischemic diseases. However, the properties of c-kit<sup>+</sup> cells in MSCs remain unclear. We investigated<bold> </bold>the differential potential of c-kit<sup>+</sup>VEGFR-2<sup>+</sup> MSCs and evaluated their effects on repai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f7c547f2-2aa0-5ff8-9080-bdf909d30634
DOI
10.21203/rs.3.rs-1235054/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
C-kit+VEGFR-2+ Mesenchymal Stem Cells Differentiate into Cardiovascular Cells and Repair Infarcted Myocardium after TransplantationDOI 10.21203/rs.3.rs-1235054/v1
Select a neighboring publication to make it the new centre.